跳至主要内容
临床试验/JPRN-jRCT1031220718
JPRN-jRCT1031220718招募中2 期

Incidence of Surgical Site Infection with or without Postoperative Antibiotics in Dermatologic Surgery (SSI-PADS): an open-label, randomized, parallel-group study - SSI-PADS Study

Yoshizaki Ayumi0 个研究点目标入组 700 人开始时间: 2023年3月21日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Those with benign or malignant lesions of the skin or subcutaneous adipose tissue of the head and neck, trunk, extremities, or limbs.
  • 2. Those with a lesion whose incision line is considered to be less than 6 cm.
  • 3. Those who undergo surgery under local anesthesia and whose reconstructive procedure is either post excisional open treatment or suture with the intention of scar healing.
  • 4. Age: 18 years of age or older at the time consent is obtained.
  • 5. Male or female.
  • 6. Those who have received a full explanation of the study and have given written consent of their own free will based on a full understanding of the study.
  • 7. Those who can make outpatient visits in accordance with the research implementation schedule.

排除标准

  • 1. Those who have taken topical, oral, or intravenous antibiotics to the planned surgical site within 48 hours prior to the surgery.
  • 2. Those subjects whose lesions to be resected are infected wounds; those who perform skin grafting and skin flap creation; those who have lesions scheduled for resection in the mucous membranes such as the oral cavity or the genital area.
  • 3. Those who are allergic to antiseptics, beta-lactam antibiotics, petroleum jelly, acetaminophen, loxoprofen.
  • 4. Those with prosthetic valve, history of endocarditis, congenital heart disease, heart transplantation, valvular repair* within the past 6 months after.
  • *Exclude mitral valve prolapse, rheumatic heart disease, bicuspid valve disease, and calcified aortic stenosis.
  • 5. Those undergoing surgery that requires placement of a drain.
  • 6. Those with infectious diseases requiring systemic treatment.
  • 7. Those with a fever of 38.0 degrees Celsius or higher at the time of registration.
  • 8. Those within 2 years of artificial joint surgery.
  • 9. Women who are pregnant, possibly pregnant, within 28 days postpartum, or breastfeeding.
  • 10. Those on immunosuppressive drugs after solid organ or bone marrow transplantation, tthose with congenital immunodeficiency syndrome, and AIDS patients.
  • 11. Those who cannot take capsules orally (e.g., during tube feeding or central intravenous nutrition).
  • 12. Those with psychiatric disorders or psychiatric symptoms that interfere with daily life and make it difficult for them to participate in the study.
  • 13. Those with poorly controlled diabetes mellitus (mean HbA1c 8.5 or higher for 3 months before surgery) or hypertension (not excluded if controlled with medication).
  • 14. Those with unstable angina (angina with onset or worsening attacks within the last 3 weeks) or a history of myocardial infarction within 6 months.
  • 15. Those with a major predisposition to bleeding (not considered a predisposition to bleeding in the following cases: taking antiplatelet agents, taking warfarin with INR<3, or using other anticoagulants).
  • 16. Others who are judged inappropriate for participation in this study by the investigator or co-investigator.

研究者

发起方
Yoshizaki Ayumi

相似试验